Endothelial cells play an important role in the antiaggregatory effect of nitric oxide

Critical Care Medicine

Volumn 31, Issue 7, 2003, Pages 2010-2014

  Klinge, Jens M ^a   Topf, Hans Georg ^a   Trusen, Burkhardt ^a   Rauh, Manfred ^a   Rascher, Wolfgang ^a   Dötsch, Jörg ^a  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

1H (1,2,4)oxadiazolo(4,3 a)quinoxalin 1 one; Adverse effects; COX inhibition; Endothelial guanylate cyclase; Nitric oxide; Platelet aggregation; S nitroso N acetyl D,L penicillamine

Indexed keywords

1H 1,2,4 OXADIAZOLO[4,3 A]QUINOXALIN 1 ONE; ACETYLSALICYLIC ACID; GUANYLATE CYCLASE INHIBITOR; INDOMETACIN; LIOMETHACIN; N ACETYL S NITROSOPENICILLAMINE; NITRIC OXIDE; PROSTACYCLIN; PROSTAGLANDIN SYNTHASE INHIBITOR;

ARTICLE; CELL CULTURE; CONTROLLED STUDY; DRUG EFFECT; ENDOTHELIUM CELL; ENZYME INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOCYTE AGGREGATION INHIBITION; THROMBOCYTE FUNCTION;

EID: 0042868216     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0000069339.42383.16     Document Type: Article

References (33)

1. Moncada S, Higgs EA: Endogenous nitric oxide: Physiology, pathology and clinical relevance. Eur J Clin Invest 1991; 21:361-374
2. Roberts JD Jr, Fineman JR, Morin FC III, et al: Inhaled nitric oxide and persistent pulmonary hypertension of the newborn. The Inhaled Nitric Oxide Study Group. N Engl J Med 1997; 336:605-610
3. Kinsella JP, Walsh WF, Bose CL, et al: Inhaled nitric oxide in premature neonates with severe hypoxaemic respiratory failure: A randomised controlled trial. Lancet 1999; 354:1061-1065
4. Cornfield DN, Maynard RC, deRegnier RA, et al: Randomized, controlled trial of low-dose inhaled nitric oxide in the treatment of term and near-term infants with respiratory failure and pulmonary hypertension. Pediatrics 1999; 104:1089-1094
5. Davidson D, Barefield ES, Kattwinkel J, et al: Inhaled nitric oxide for the early treatment of persistent pulmonary hypertension of the term newborn: A randomized, double-masked, placebo-controlled, dose-response, multicenter study. The I-NO/PPHN Study Group. Pediatrics 1998; 101:325-334
6. Gothberg S, Edberg KE: Inhaled nitric oxide to newborns and infants after congenital heart surgery on cardiopulmonary bypass. A dose-response study. Scand Cardiovasc J 2000; 34:154-158
7. Laitinen PO, Rasanen J, Sairanen H: Postoperative nitric oxide therapy in children with congenital heart disease. Can the need be predicted? Scand Cardiovasc J 2000; 34:149-153
8. Beghetti M, Morris K, Cox P, et al: Inhaled nitric oxide differentiates pulmonary vasospasm from vascular obstruction after surgery for congenital heart disease. Intensive Care Med 1999; 25:1126-1130
9. Day RW, Hawkins JA, McGough EC, et al: Randomized controlled study of inhaled nitric oxide after operation for congenital heart disease. Ann Thorac Surg 2000; 69:1907-1912
10. Hovenga S, Koenders ME, van der Werf TS, et al: Methaemoglobinaemia after inhalation of nitric oxide for treatment of hydrochlorothiazide-induced pulmonary oedema. Lancet 1996; 348:1035-1036
11. Dötsch J, Demirakca S, Hamm R, et al: Extracorporeal circulation increases nitric oxide-induced methemoglobinemia in vivo and in vitro. Crit Care Med 1997; 25:1153-1158
12. Dötsch J, Demirakca S, Hahn D, et al: Accuracy of methemoglobin measurements: Comparison of six different commercial devices and one manual method. Crit Care Med 1999; 27:1191-1194
13. Dötsch J, Demirakca S, Kratz M, et al: Comparison of methylene blue, riboflavin, and N-acetylcysteine for the reduction of nitric oxide-induced methemoglobinemia. Crit Care Med 2000; 28:958-961
14. Daher AH, Fortenberry JD, Owens ML, et al: Effects of exogenous nitric oxide on neutrophil oxidative function and viability. Am J Respir Cell Mol Biol 1997; 16:407-412
15. Fortenberry JD, Owens ML, Brown MR, et al: Exogenous nitric oxide enhances neutrophil cell death and DNA fragmentation. Am J Respir Cell Mol Biol 1998; 18:421-428
16. Radomski MW, Vallance P, Whitley G, et al: Platelet adhesion to human vascular endothelium is modulated by constitutive and cytokine induced nitric oxide. Cardiovasc Res 1993; 27:1380-1382
17. Kurata M, Tanaka K, Usami M: Different roles of endothelium-derived substances on inhibiting platelet aggregation in whole blood. Gen Pharmacol 1997; 28:671-673
18. Broekman MJ, Eiroa AM, Marcus AJ: Inhibition of human platelet reactivity by endothelium-derived relaxing factor from human umbilical vein endothelial cells in suspension: Blockade of aggregation and secretion by an aspirin-insensitive mechanism. Blood 1991; 78:1033-1040
19. Cheung PY, Salas E, Etches PC, et al: Inhaled nitric oxide and inhibition of platelet aggregation in critically ill neonates. Lancet 1998; 351:1181-1182
20. Brune B, Hanstein K: Rapid reversibility of nitric oxide induced platelet inhibition. Thromb Res 1998; 90:83-91
21. Mellgren K, Friberg LG, Mellgren G, et al: Nitric oxide in the oxygenator sweep gas reduces platelet activation during experimental perfusion. Ann Thorac Surg 1996; 61:1194-1198
22. Mellgren K, Mellgren G, Lundin S, et al: Effect of nitric oxide gas on platelets during open heart operations. Ann Thorac Surg 1998; 65:1335-1341
23. Moro MA, Russel RJ, Cellek S, et al: cGMP mediates the vascular and platelet actions of nitric oxide: Confirmation using an inhibitor of the soluble guanylyl cyclase. Proc Natl Acad Sci U S A 1996; 93:1480-1485
24. Nielsen VG, Geary BT, Baird MS: Effects of DETANONOate, a nitric oxide donor, on hemostasis in rabbits: An in vitro and in vivo thrombelastographic analysis. J Crit Care 2000; 15:30-35
25. Dambisya YM, Lee TL: A thromboelastography study on the in vitro effects of L-arginine and L-NG-nitro arginine methyl ester on human whole blood coagulation and fibrinolysis. Blood Coagul Fibrinolysis 1996; 7:678-683
26. George TN, Johnson KJ, Bates JN, et al: The effect of inhaled nitric oxide therapy on bleeding time and platelet aggregation in neonates. J Pediatr 1998; 132:731-734
27. Hogman M, Frostell C, Arnberg H, et al: Bleeding time prolongation and NO inhalation. Lancet 1993; 341:1664-1665
28. Furlong B, Henderson AH, Lewis MJ, et al: Endothelium-derived relaxing factor inhibits in vitro platelet aggregation. Br J Pharmacol 1987; 90:687-692
29. Vane JR, Anggard EE, Botting RM: Regulatory functions of the vascular endothelium. N Engl J Med 1990; 323:27-36
30. Salvemini D, Masferrer JL: Interactions of nitric oxide with cyclooxygenase: In vitro, ex vivo, and in vivo studies. Methods Enzymol 1996; 269:12-25
31. Dötsch J, Demirakca S, Zepf K, et al: Recovery from withdrawal of inhaled nitric oxide and kinetics of nitric oxide-induced inhibition of nitric oxide synthase activity in vitro. Intensive Care Med 2000; 26:330-335
32. Radomski MW, Palmer RM, Moncada S: The anti-aggregating properties of vascular endothelium: Interactions between prostacyclin and nitric oxide. Br J Pharmacol 1987; 92:639-646
33. Konturek S, Pawlik W: Physiology and pharmacology of prostaglandins. Dig Dis Sci 1986; 31 (Suppl 2):6S-19S